US 10857225
Smallpox vaccine for cancer treatment
granted A61KA61K2039/515A61K2039/525
Quick answer
US patent 10857225 (Smallpox vaccine for cancer treatment) held by Calidi Biotherapeutics, Inc. expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Calidi Biotherapeutics, Inc.
- Grant date
- Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K2039/515, A61K2039/525, A61K2039/5254, A61K2039/55